Teva is a pharmaceutical company that researches and commercializes generic tablets and capsules for respiratory and central nervous system disorders.Read more
Abbott is the top competitor of TEVA. Abbott is a Public company that was founded in Abbott Park, Illinois in 1888. Abbott operates in the Health Care Equipment industry. Abbott has 66,465 more employees vs. TEVA.
Merck is seen as one of TEVA's biggest rivals. Merck was founded in Kenilworth, New Jersey} in 1891. Like TEVA, Merck also operates in the Pharmaceuticals sector. Compared to TEVA, Merck generates $31.7B more revenue.
TEVA's revenue is the ranked 16th among it's top 10 competitors. The top 10 competitors average 27.7B. Over the last four quarters, TEVA's revenue has grown by 2.9%. Specifically, in Q1 2021's revenue was $4B; in Q4 2020, it was $4.5B; in Q3 2020, it was $4B; in Q2 2020, TEVA's revenue was $3.9B.